Third Security’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,810
Closed -$354K 12
2021
Q1
$354K Hold
3,810
0.05% 5
2020
Q4
$341K Hold
3,810
0.03% 9
2020
Q3
$394K Hold
3,810
0.08% 12
2020
Q2
$301K Hold
3,810
0.05% 10
2020
Q1
$220K Hold
3,810
0.05% 10
2019
Q4
$206K Buy
+3,810
New +$207K 0.03% 11
2019
Q1
Sell
-3,810
Closed -$226K 13
2018
Q4
$226K Hold
3,810
0.03% 14
2018
Q3
$251K Buy
+3,810
New +$222K 0.02% 16

Other funds holding EBS

Third Security's EBS Position: Q2 2021 in Review

Third Security sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 3,810 shares — an estimated $354K sold.

Third Security first reported a position in EBS in Q3 2018 and held it in 8 quarters. The position peaked at $394K in Q3 2020. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

  • Third Security reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
  • Third Security sold 3,810 Emergent Biosolutions shares in Q2 2021, an estimated $354K.
  • Third Security first reported a position in Emergent Biosolutions in Q3 2018 and held it in 8 quarters.
  • Third Security's Emergent Biosolutions position peaked at $394K in Q3 2020.
  • 290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on Third Security's 13F filing for Q2 2021, filed 12 Aug 2021.